Diabetes Devices Market Share

North American Market Forecast

The North America diabetes devices market is projected to hold the largest market share by the end of 2036 on the back of an increase in the prevalence of diabetes cases, rising healthcare expenditure, and the growing presence of dominant players in insulin syringe manufacturers. The healthcare expenditure of the U.S in 2020 rose to 9.7% and is estimated to reach USD 4.1 trillion. Further, the presence of a strong healthcare network in the region, along with the availability of supportive policies by the regulatory bodies that promote the market players to opt for easy testing of newly launched devices over a large target population so as to develop efficient treatment options and glucose monitoring options, are also expected to contribute to the market growths in the region. In addition, the region's expanding healthcare industry and rising commercialization of diabetes device products are also predicted to fuel the market growth notably over the projected period.